References
1a
Oh CH.
Rhim CY.
Kang JH.
Kim A.
Park BS.
Seo Y.
Tetrahedron Lett.
1996,
37:
8875
1b
Oh CH.
Rhim CY.
Jung HH.
Jung SH.
Bull. Korean Chem. Soc.
1999,
20:
643
2
Hanssen HP.
Abraham WR.
Tetrahedron
1988,
44:
2175
For reviews, see:
3a
Mehta G.
Srikrishna A.
Chem. Rev.
1997,
97:
671
3b
Singh V.
Thomas B.
Tetrahedron
1998,
54:
3647
4a
Hayano K.
Ohfune Y.
Shirahama H.
Matsumoto T.
Helv. Chim. Acta
1981,
64:
1347
4b
Comer FW.
McCapra F.
Qureshi IH.
Scott AI.
Tetrahedron
1967,
23:
4761
5a
Paquette LA.
Geng F.
J. Am. Chem. Soc.
2002,
124:
9199
5b
Mukai C.
Kobayashi M.
Kim IJ.
Hanaoka M.
Tetrahedron
2002,
58:
5225
5c
Anger T.
Graalmann O.
Schröder H.
Gerke R.
Kaiser U.
Fitjer L.
Noltemeyer M.
Tetrahedron
1998,
54:
10713
5d
Baralotto C.
Chanon M.
Julliard M.
J. Org. Chem.
1996,
61:
3576
5e
Clive DLJ.
Magnuson SR.
Tetrahedron Lett.
1995,
36:
15
5f
Metha G.
Karra SR.
J. Chem. Soc., Chem. Commun.
1991,
1367
6a
Almqvist F.
Frejd T.
Tetrahedron: Asymmetry
1995,
6:
957
6b
Shenvi AB.
Gerlach H.
Helv. Chim. Acta
1980,
63:
2426
Similar types of alkylpalladium intermediates bearing a β-hydrogen are prone to undergo elimination to the corresponding alkenes. For reviews, see:
7a
Trost BM.
Science
1991,
254:
1471
7b
Trost BM.
Acc. Chem. Res.
1990,
23:
34
7c
Trost BM.
Shi Y.
J. Am. Chem. Soc.
1993,
115:
12491
For the use of formic acid or formates as a hydrogen donor in palladium-mediated reactions, see:
8a
Tsuji J.
Palladium Reagents and Catalysts
Wiley;
Chichester:
1995.
8b
Tsuji J.
Mandai T.
Synthesis
1996,
1
8c
Trost BM.
Li Y.
J. Am. Chem. Soc.
1996,
118:
6625
8d
Oh CH.
Jung HH.
Sung HR.
Kim JD.
Tetrahedron
2001,
57:
1723
8e
Oh CH.
Park SJ.
Tetrahedron Lett.
2003,
44:
3785
9a
Lipshutz BH.
Sengupta S.
Org. React.
1992,
41:
136
9b
Krause N.
Hoffmann-Röder A.
Synthesis
2001,
171
10
Furrow ME.
Myers AG.
J. Am. Chem. Soc.
2004,
126:
5436
11
Piers E.
Orellana A.
Synthesis
2001,
2138
12
Shono T.
Kise N.
Fujimoto T.
Tominga N.
Morita H.
J. Org. Chem.
1992,
57:
7175
13a
Barton DHR.
McCombie SW.
J. Chem. Soc., Perkin Trans. 1
1975,
1574
13b
Metha G.
Umarye JD.
Tetrahedron Lett.
2001,
42:
1991
13c
Keller VA.
Kim I.
Burke SD.
Org. Lett.
2005,
7:
737
14
Harrowven DC.
Guy IL.
Chem. Commun.
2004,
1968
15 All new compounds were fully characterized by 1H NMR, 13C NMR, IR, HRMS (or elemental analysis).
Ceratopicanol (
11): 1H NMR (400 MHz, CDCl3): δ = 3.71 (dd, J = 10.0, 7.2 Hz, 1 H), 2.49 (m, 1 H), 2.34 (ddd, J = 11.3, 8.3, 8.3 Hz, 1 H), 2.15 (dd, J = 14.0, 9.6 Hz, 1 H), 1.88 (m, 1 H), 1.67 (ddd, J = 13.0, 8.4, 1.2 Hz, 1 H), 1.56 (m, 1 H), 1.50-1.32 (m, 5 H), 1.23 (dd, J = 13.0, 4.8 Hz, 1 H), 1.08 (dd, J = 13.8, 6.8 Hz, 1 H), 1.04 (s, 6 H), 0.88 (s, 3 H), 0.87 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 82.62, 58.80, 54.96, 51.23, 48.77, 44.18, 41.94, 41.68, 40.85, 39.56, 31.54, 30.60, 28.54, 23.66, 21.25. FT-IR (neat): 3310 (-OH, br s) cm-1.
Isomer of Ceratopicanol (11β): 1H NMR (400 MHz, CDCl3): δ = 3.88 (m, 1 H), 2.64 (h, J = 8.0 Hz, 1 H), 2.45 (dt, J = 11.2, 9.6 Hz, 1 H), 2.08 (dtd, J = 13.6, 9.2, 5.6 Hz, 1 H), 1.79 (ddd, J = 11.6, 11.4, 5.6 Hz, 1 H), 1.65-1.54 (m, 2 H), 1.46 (s, 1 H), 1.44 (s, 1 H), 1.38 (ddd, J = 12.8, 8.8, 2.0 Hz, 1 H), 1.31 (d, J = 4.0 Hz, 1 H), 1.28 (m, 1 H), 1.11-1.06 (m, 2 H), 1.04 (s, 3 H), 0.95 (s, 3 H), 0.91 (s, 3 H), 0.79 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 81.16, 59.62, 54.63, 52.27, 49.83, 44.25, 41.44, 40.97, 39.85, 32.81, 30.25, 29.35, 28.15, 23.69, 19.63. FT-IR (neat): 3320 (-OH, br s) cm-1. HRMS (ES): m/z calcd for C15H26ONa+: 245.1881; found: 245.1872.